Schedule 13G ownership disclosure

Vor BioPharma Inc

Common Stock, $0.0001 par value per share · CUSIP: 929033207

Event date: 2025-12-10

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Great Point Partners, LLC

    Shares: 1,234,486.00 · Class: 5.63%

  • Dr. Jeffrey R. Jay, M.D.

    Shares: 1,234,486.00 · Class: 5.63%

  • Ms. Lillian Nordahl

    Shares: 1,234,486.00 · Class: 5.63%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001172661-25-005271
Form type
SCHEDULE 13G
Filer
GREAT POINT PARTNERS LLC
CIK
CIK 1281446
Filed
Dec 17, 2025
Reporting period
Dec 10, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub